SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-244646
Filing Date
2021-08-12
Accepted
2021-08-12 16:02:23
Documents
47
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d156733d10q.htm   iXBRL 10-Q 1149193
2 EX-10.1 d156733dex101.htm EX-10.1 81994
3 EX-10.2 d156733dex102.htm EX-10.2 83964
4 EX-31.1 d156733dex311.htm EX-31.1 10337
5 EX-31.2 d156733dex312.htm EX-31.2 10345
6 EX-32.1 d156733dex321.htm EX-32.1 5207
12 GRAPHIC g156733cymabaylogo.jpg GRAPHIC 6089
  Complete submission text file 0001193125-21-244646.txt   4509441

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbay-20210630.xsd EX-101.SCH 29839
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20210630_cal.xml EX-101.CAL 24663
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20210630_def.xml EX-101.DEF 140567
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20210630_lab.xml EX-101.LAB 251746
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20210630_pre.xml EX-101.PRE 189881
13 EXTRACTED XBRL INSTANCE DOCUMENT d156733d10q_htm.xml XML 670351
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 211167407
SIC: 2834 Pharmaceutical Preparations